Search results
Tech wrap Jul 3: Samsung Galaxy Book 4 Ultra, Meta AI in WhatsApp, and more
Business Standard India· 4 days agoThe Galaxy Book 4 Ultra is powered by Intel Core Ultra processors and features advanced artificial...
EAN 2024: Opicapone demonstrates efficacy in real-world clinical practice
Clinical Trials Arena· 3 days agoIt was conducted in 16 Spanish health centres and enrolled 245 patients, all of whom were on...
EMA approves Sanofi’s Dupixent for COPD treatment in adults
Pharmaceutical Technology· 5 days agoPatients treated with Dupixent also reported enhancements in health-related quality of life, with...
New Electronic Warfare Pod Turns Marine MQ-9 Reaper Into “A Black Hole”
THE WARZONE· 5 days agoTo keep its small fleet of MQ-9 Reaper drones relevant in a fight against a foe like China, the U.S....
How Metallica changed the game forever with a "sloppy" little demo track called Hit The Lights
Louder Sound· 5 days agoYet those who were paying attention knew that it signified a change, one that would come to fruition...
Now could be the worst time ever to launch a new MTB, so how are bike brands handling that?
Bike Perfect· 3 days agoThe new Genie shock has rubbed some people up the wrong way (Image credit: GuyKesTV) New stuff is...
Northwest ecosystems changed dramatically when wolves were nearly exterminated, study finds
Washington State Standard· 2 days agoEcosystems in the Northwest were heavily shaped by wolves before they were nearly wiped out of the...
Wimbledon PIX: Raducanu, Badosa score upset wins
rediff.com· 2 days agoWhen Emma Raducanu nonchalantly flicked a lob that appeared to be drifting long before it dropped inches inside the baseline to earn her a break and a...
Wimbledon 2024: On fire Raducanu beats Sakkari to reach last 16
Sportstar· 2 days agoRaducanu will next play New Zealand qualifier Lulu Sun for a place in the quarter-finals.
EAN 2024: sublingual apomorphine better tolerated by dopamine agonist users
Pharmaceutical Technology· 3 days agoThe post-hoc analysis separated the trial participants into DA users and non-DA users at baseline,...